Search Results - "Sutherland, Claire L."
-
1
Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors
Published in Biochimica et biophysica acta (01-12-2011)“…Indoleamine 2,3-dioxygenase (IDO1) catalyzes the first step in tryptophan breakdown along the kynurenine pathway. Therapeutic inhibition of IDO1 is receiving…”
Get full text
Journal Article -
2
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity
Published in The Journal of experimental medicine (02-06-2003)“…The activating receptor, NKG2D, is expressed on a variety of immune effector cells and recognizes divergent families of major histocompatibility complex (MHC)…”
Get full text
Journal Article -
3
UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells
Published in The Journal of immunology (1950) (15-01-2002)“…The UL16-binding proteins (ULBPs) are a novel family of MHC class I-related molecules that were identified as targets of the human CMV glycoprotein, UL16. We…”
Get full text
Journal Article -
4
A RANK/TRAF6-dependent Signal Transduction Pathway Is Essential for Osteoclast Cytoskeletal Organization and Resorptive Function
Published in The Journal of biological chemistry (15-11-2002)“…Signaling through receptor activator of nuclear factor-κB (RANK) is essential for the differentiation and activation of osteoclasts, the cell principally…”
Get full text
Journal Article -
5
The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions
Published in Immunological reviews (01-07-2001)“…The UL16‐binding proteins (ULBPs) are a novel family of MHC class I‐related molecules (MICs) that were identified based on their ability to bind to the human…”
Get full text
Journal Article -
6
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema
Published in Journal of neuropathology and experimental neurology (01-10-2018)“…Abstract Chimeric antigen receptor (CAR) T cells are a new and powerful class of cancer immunotherapeutics that have shown potential for the treatment of…”
Get full text
Journal Article -
7
Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues: Potential Implications as a Cancer Therapeutic Target
Published in The journal of histochemistry and cytochemistry (01-07-2011)“…Trop2 is a cell-surface glycoprotein reported to be overexpressed in various types of adenocarcinomas with minimal expression in normal tissues. Recent…”
Get full text
Journal Article -
8
ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
Published in Immunity (Cambridge, Mass.) (01-02-2001)“…The human cytomegalovirus glycoprotein, UL16, binds to two members of a novel family of molecules, the ULBPs, and to the MHC class I homolog, MICB. The ULBPs…”
Get full text
Journal Article -
9
ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15
Published in Blood (15-08-2006)“…ULBPs are human ligands for NKG2D, an activating receptor expressed on natural killer (NK) cells, NK1.1+ T cells, and T cells. ULBPs are expressed by a variety…”
Get full text
Journal Article -
10
Dendritic cell survival and maturation are regulated by different signaling pathways
Published in The Journal of experimental medicine (07-12-1998)“…Although dendritic cell (DC) activation is a critical event for the induction of immune responses, the signaling pathways involved in this process have not…”
Get full text
Journal Article -
11
ULBP4 is a novel ligand for human NKG2D
Published in Biochemical and biophysical research communications (23-05-2003)“…The ULBPs are a family of MHC class I-related molecules. We have previously shown that ULBPs 1, 2, and 3 are functional ligands of the NKG2D/DAP10 receptor…”
Get full text
Journal Article -
12
Listeria monocytogenes Invasion of Epithelial Cells Requires the MEK-1/ERK-2 Mitogen-Activated Protein Kinase Pathway
Published in Infection and Immunity (01-03-1998)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
13
Tumor gene signature associated with neurotoxicity in R/R B-ALL patients treated with JCAR015, a CD19-directed CAR T cell product
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
14
Pharmacokinetic, Pharmacodynamic and Blood Analytes Associated with Clinical Response and Safety in Relapsed/Refractory Aggressive B-NHL Patients Treated with JCAR017
Published in Blood (08-12-2017)“…Introduction: JCAR017 is a CD19-directed 4-1BB CAR T cell product administered in a defined composition at a precise dose of CD8 and CD4 CAR T cells. TRANSCEND…”
Get full text
Journal Article -
15
Predicting Clinical Response and Safety of JCAR017 in B-NHL Patients: Potential Importance of Tumor Microenvironment Biomarkers and CAR T-Cell Tumor Infiltration
Published in Blood (08-12-2017)“…▪ Introduction: JCAR017 is a CD19-directed 4-1BB CAR T-cell product administered in a defined composition at a precise dose of CD8 and CD4 CAR T cells…”
Get full text
Journal Article -
16
Patient Characteristics and Pre-Infusion Biomarkers of Inflammation Correlate with Clinical Outcomes after Treatment with the Defined Composition, CD19-Targeted CAR T Cell Product, JCAR017
Published in Blood (08-12-2017)“…▪ Introduction JCAR017 is a CD19-directed 4-1BB CAR T cell product candidate administered in a defined composition at a precise dose of CD8 and CD4 CAR T…”
Get full text
Journal Article -
17
Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
Published in The Journal of immunology (1950) (15-10-1996)“…B cell antigen receptor (BCR)-induced apoptosis in the WEHI-231 B lymphoma cell line can be prevented by engaging CD40. We have used this cell line to…”
Get full text
Journal Article -
18
An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of WEHI-231 cells from anti-IgM-induced growth arrest
Published in The Journal of immunology (1950) (15-04-1999)“…We have previously shown that CD40 causes strong activation of the c-Jun N-terminal kinase (JNK), the p38 mitogen-activated protein kinases (MAPK) and MAPKAP…”
Get full text
Journal Article -
19
Purification and identification of tyrosine-phosphorylated proteins from B lymphocytes stimulated through the antigen receptor
Published in Electrophoresis (1994)“…The activation of protein tyrosine kinase (PTKs) and subsequent tyrosine phosphorylation of cellular proteins is a critical initial signal in the response of…”
Get more information
Journal Article -
20
An 11-Amino Acid Sequence in the Cytoplasmic Domain of CD40 Is Sufficient for Activation of c-Jun N-Terminal Kinase, Activation of MAPKAP Kinase-2, Phosphorylation of I{kappa}B{alpha}, and Protection of WEHI-231 Cells from Anti-IgM-Induced Growth Arrest
Published in The Journal of immunology (1950) (15-04-1999)Get full text
Journal Article